Novo Nordisk’ chief executive Lars Fruergaard Jørgensen has agreed to appear at a Senate ... representative in the GLP-1 agonist market to testify at the hearing.

The CEO of Novo Nordisk plans to blame drug middlemen ... of the diabetes and weight loss drugs in April. Jorgensen agreed in June to testify, after Sanders had threatened him with a subpoena.

Sept. 24 (UPI) --The CEO of Novo Nordisk is on Capitol Hill Tuesday to testify before a Senate committee about the high costs of its drugs Ozempic and Wegovy. Chairman Sen. Bernie Sanders ...

Sen. Bernie Sanders, I-Vt., says the first question he is going to ask Novo Nordisk's CEO at a Senate committee hearing in September is why the drugmaker charges up to 10 or 15 times more for ...

Jørgensen has agreed to serve as the company’s CEO on an interim basis until his replacement is found. The Danish pharma giant added that Lars Rebien Sørensen, chair of the Novo Nordisk ...

Novo Nordisk is parting ways with its CEO Lars Fruergaard Jørgensen after the two parties mutually agreed that a change of leadership was required amid fierce glucagon-like peptide 1 receptor ...

The Danish drugmaker on Friday abruptly announced that longtime CEO Lars ... of several of Novo Nordisk's other recent tie-ups. For example, Novo Nordisk in March said it had agreed to pay up ...